Document is current

Disease control with brentuximab vedotin in an aged patient with primary cutaneous anaplastic large-cell lymphoma

Crossref DOI link: https://doi.org/10.1007/s12254-017-0325-5

Published Online: 2017-03-27

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy